Pharma & Healthcare
Global Treatment for Gastroparesis Market Research Report 2026
- Nov 14, 26
- ID: 765178
- Pages: 126
- Figures: 127
- Views: 4
The global Treatment for Gastroparesis market was valued at US$ 6407 million in 2025 and is anticipated to reach US$ 8568 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Treatment for Gastroparesis competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Treatment for Gastroparesis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Treatment for Gastroparesis. The Treatment for Gastroparesis market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Treatment for Gastroparesis market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Treatment for Gastroparesis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Janssen Global Services
Evoke Pharma
Cardinal Health
Salix Pharmaceuticals
Alfa Wassermann
Abbott Laboratories
Medtronic
C.R.Bard
Rhythm Pharmaceuticals
Boston Scientific
Kimberly-Clark
Segment by Type
Drugs
Surgical Treatment Products
by Application
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Treatment for Gastroparesis manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Treatment for Gastroparesis sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Treatment for Gastroparesis competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Treatment for Gastroparesis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Treatment for Gastroparesis. The Treatment for Gastroparesis market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Treatment for Gastroparesis market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Treatment for Gastroparesis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Janssen Global Services
Evoke Pharma
Cardinal Health
Salix Pharmaceuticals
Alfa Wassermann
Abbott Laboratories
Medtronic
C.R.Bard
Rhythm Pharmaceuticals
Boston Scientific
Kimberly-Clark
Segment by Type
Drugs
Surgical Treatment Products
by Application
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Treatment for Gastroparesis manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Treatment for Gastroparesis sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Treatment for Gastroparesis Market Overview
1.1 Product Definition
1.2 Treatment for Gastroparesis by Type
1.2.1 Global Treatment for Gastroparesis Market Value by Type: 2025 vs 2032
1.2.2 Drugs
1.2.3 Surgical Treatment Products
1.3 Treatment for Gastroparesis by Application
1.3.1 Global Treatment for Gastroparesis Market Value by Application: 2025 vs 2032
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Drug Stores
1.3.5 Retail Pharmacies
1.3.6 E-Commerce
1.4 Global Treatment for Gastroparesis Market Size Estimates and Forecasts
1.4.1 Global Treatment for Gastroparesis Revenue 2021–2032
1.4.2 Global Treatment for Gastroparesis Sales 2021–2032
1.4.3 Global Treatment for Gastroparesis Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Treatment for Gastroparesis Market Competition by Manufacturers
2.1 Global Treatment for Gastroparesis Sales Market Share by Manufacturers (2021–2026)
2.2 Global Treatment for Gastroparesis Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Treatment for Gastroparesis Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Treatment for Gastroparesis, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Treatment for Gastroparesis, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Treatment for Gastroparesis, Product Types and Applications
2.7 Global Key Manufacturers of Treatment for Gastroparesis, Date of Entry into the Industry
2.8 Global Treatment for Gastroparesis Market Competitive Situation and Trends
2.8.1 Global Treatment for Gastroparesis Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Treatment for Gastroparesis Players Market Share by Revenue
2.8.3 Global Treatment for Gastroparesis Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Treatment for Gastroparesis Market Scenario by Region
3.1 Global Treatment for Gastroparesis Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Treatment for Gastroparesis Sales by Region: 2021–2032
3.2.1 Global Treatment for Gastroparesis Sales by Region: 2021–2026
3.2.2 Global Treatment for Gastroparesis Sales by Region: 2027–2032
3.3 Global Treatment for Gastroparesis Revenue by Region: 2021–2032
3.3.1 Global Treatment for Gastroparesis Revenue by Region: 2021–2026
3.3.2 Global Treatment for Gastroparesis Revenue by Region: 2027–2032
3.4 North America Treatment for Gastroparesis Market Facts & Figures by Country
3.4.1 North America Treatment for Gastroparesis Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Treatment for Gastroparesis Sales by Country (2021–2032)
3.4.3 North America Treatment for Gastroparesis Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Treatment for Gastroparesis Market Facts & Figures by Country
3.5.1 Europe Treatment for Gastroparesis Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Treatment for Gastroparesis Sales by Country (2021–2032)
3.5.3 Europe Treatment for Gastroparesis Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Treatment for Gastroparesis Market Facts & Figures by Region
3.6.1 Asia Pacific Treatment for Gastroparesis Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Treatment for Gastroparesis Sales by Region (2021–2032)
3.6.3 Asia Pacific Treatment for Gastroparesis Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Treatment for Gastroparesis Market Facts & Figures by Country
3.7.1 Latin America Treatment for Gastroparesis Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Treatment for Gastroparesis Sales by Country (2021–2032)
3.7.3 Latin America Treatment for Gastroparesis Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Treatment for Gastroparesis Market Facts & Figures by Country
3.8.1 Middle East and Africa Treatment for Gastroparesis Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Treatment for Gastroparesis Sales by Country (2021–2032)
3.8.3 Middle East and Africa Treatment for Gastroparesis Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Treatment for Gastroparesis Sales by Type (2021–2032)
4.1.1 Global Treatment for Gastroparesis Sales by Type (2021–2026)
4.1.2 Global Treatment for Gastroparesis Sales by Type (2027–2032)
4.1.3 Global Treatment for Gastroparesis Sales Market Share by Type (2021–2032)
4.2 Global Treatment for Gastroparesis Revenue by Type (2021–2032)
4.2.1 Global Treatment for Gastroparesis Revenue by Type (2021–2026)
4.2.2 Global Treatment for Gastroparesis Revenue by Type (2027–2032)
4.2.3 Global Treatment for Gastroparesis Revenue Market Share by Type (2021–2032)
4.3 Global Treatment for Gastroparesis Price by Type (2021–2032)
5 Segment by Application
5.1 Global Treatment for Gastroparesis Sales by Application (2021–2032)
5.1.1 Global Treatment for Gastroparesis Sales by Application (2021–2026)
5.1.2 Global Treatment for Gastroparesis Sales by Application (2027–2032)
5.1.3 Global Treatment for Gastroparesis Sales Market Share by Application (2021–2032)
5.2 Global Treatment for Gastroparesis Revenue by Application (2021–2032)
5.2.1 Global Treatment for Gastroparesis Revenue by Application (2021–2026)
5.2.2 Global Treatment for Gastroparesis Revenue by Application (2027–2032)
5.2.3 Global Treatment for Gastroparesis Revenue Market Share by Application (2021–2032)
5.3 Global Treatment for Gastroparesis Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Janssen Global Services
6.1.1 Janssen Global Services Company Information
6.1.2 Janssen Global Services Description and Business Overview
6.1.3 Janssen Global Services Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Janssen Global Services Treatment for Gastroparesis Product Portfolio
6.1.5 Janssen Global Services Recent Developments/Updates
6.2 Evoke Pharma
6.2.1 Evoke Pharma Company Information
6.2.2 Evoke Pharma Description and Business Overview
6.2.3 Evoke Pharma Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Evoke Pharma Treatment for Gastroparesis Product Portfolio
6.2.5 Evoke Pharma Recent Developments/Updates
6.3 Cardinal Health
6.3.1 Cardinal Health Company Information
6.3.2 Cardinal Health Description and Business Overview
6.3.3 Cardinal Health Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Cardinal Health Treatment for Gastroparesis Product Portfolio
6.3.5 Cardinal Health Recent Developments/Updates
6.4 Salix Pharmaceuticals
6.4.1 Salix Pharmaceuticals Company Information
6.4.2 Salix Pharmaceuticals Description and Business Overview
6.4.3 Salix Pharmaceuticals Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Salix Pharmaceuticals Treatment for Gastroparesis Product Portfolio
6.4.5 Salix Pharmaceuticals Recent Developments/Updates
6.5 Alfa Wassermann
6.5.1 Alfa Wassermann Company Information
6.5.2 Alfa Wassermann Description and Business Overview
6.5.3 Alfa Wassermann Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Alfa Wassermann Treatment for Gastroparesis Product Portfolio
6.5.5 Alfa Wassermann Recent Developments/Updates
6.6 Abbott Laboratories
6.6.1 Abbott Laboratories Company Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Abbott Laboratories Treatment for Gastroparesis Product Portfolio
6.6.5 Abbott Laboratories Recent Developments/Updates
6.7 Medtronic
6.7.1 Medtronic Company Information
6.7.2 Medtronic Description and Business Overview
6.7.3 Medtronic Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Medtronic Treatment for Gastroparesis Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 C.R.Bard
6.8.1 C.R.Bard Company Information
6.8.2 C.R.Bard Description and Business Overview
6.8.3 C.R.Bard Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 C.R.Bard Treatment for Gastroparesis Product Portfolio
6.8.5 C.R.Bard Recent Developments/Updates
6.9 Rhythm Pharmaceuticals
6.9.1 Rhythm Pharmaceuticals Company Information
6.9.2 Rhythm Pharmaceuticals Description and Business Overview
6.9.3 Rhythm Pharmaceuticals Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Rhythm Pharmaceuticals Treatment for Gastroparesis Product Portfolio
6.9.5 Rhythm Pharmaceuticals Recent Developments/Updates
6.10 Boston Scientific
6.10.1 Boston Scientific Company Information
6.10.2 Boston Scientific Description and Business Overview
6.10.3 Boston Scientific Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Boston Scientific Treatment for Gastroparesis Product Portfolio
6.10.5 Boston Scientific Recent Developments/Updates
6.11 Kimberly-Clark
6.11.1 Kimberly-Clark Company Information
6.11.2 Kimberly-Clark Description and Business Overview
6.11.3 Kimberly-Clark Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Kimberly-Clark Treatment for Gastroparesis Product Portfolio
6.11.5 Kimberly-Clark Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Treatment for Gastroparesis Industry Chain Analysis
7.2 Treatment for Gastroparesis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Treatment for Gastroparesis Production Mode & Process Analysis
7.4 Treatment for Gastroparesis Sales and Marketing
7.4.1 Treatment for Gastroparesis Sales Channels
7.4.2 Treatment for Gastroparesis Distributors
7.5 Treatment for Gastroparesis Customer Analysis
8 Treatment for Gastroparesis Market Dynamics
8.1 Treatment for Gastroparesis Industry Trends
8.2 Treatment for Gastroparesis Market Drivers
8.3 Treatment for Gastroparesis Market Challenges
8.4 Treatment for Gastroparesis Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Treatment for Gastroparesis by Type
1.2.1 Global Treatment for Gastroparesis Market Value by Type: 2025 vs 2032
1.2.2 Drugs
1.2.3 Surgical Treatment Products
1.3 Treatment for Gastroparesis by Application
1.3.1 Global Treatment for Gastroparesis Market Value by Application: 2025 vs 2032
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Drug Stores
1.3.5 Retail Pharmacies
1.3.6 E-Commerce
1.4 Global Treatment for Gastroparesis Market Size Estimates and Forecasts
1.4.1 Global Treatment for Gastroparesis Revenue 2021–2032
1.4.2 Global Treatment for Gastroparesis Sales 2021–2032
1.4.3 Global Treatment for Gastroparesis Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Treatment for Gastroparesis Market Competition by Manufacturers
2.1 Global Treatment for Gastroparesis Sales Market Share by Manufacturers (2021–2026)
2.2 Global Treatment for Gastroparesis Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Treatment for Gastroparesis Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Treatment for Gastroparesis, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Treatment for Gastroparesis, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Treatment for Gastroparesis, Product Types and Applications
2.7 Global Key Manufacturers of Treatment for Gastroparesis, Date of Entry into the Industry
2.8 Global Treatment for Gastroparesis Market Competitive Situation and Trends
2.8.1 Global Treatment for Gastroparesis Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Treatment for Gastroparesis Players Market Share by Revenue
2.8.3 Global Treatment for Gastroparesis Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Treatment for Gastroparesis Market Scenario by Region
3.1 Global Treatment for Gastroparesis Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Treatment for Gastroparesis Sales by Region: 2021–2032
3.2.1 Global Treatment for Gastroparesis Sales by Region: 2021–2026
3.2.2 Global Treatment for Gastroparesis Sales by Region: 2027–2032
3.3 Global Treatment for Gastroparesis Revenue by Region: 2021–2032
3.3.1 Global Treatment for Gastroparesis Revenue by Region: 2021–2026
3.3.2 Global Treatment for Gastroparesis Revenue by Region: 2027–2032
3.4 North America Treatment for Gastroparesis Market Facts & Figures by Country
3.4.1 North America Treatment for Gastroparesis Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Treatment for Gastroparesis Sales by Country (2021–2032)
3.4.3 North America Treatment for Gastroparesis Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Treatment for Gastroparesis Market Facts & Figures by Country
3.5.1 Europe Treatment for Gastroparesis Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Treatment for Gastroparesis Sales by Country (2021–2032)
3.5.3 Europe Treatment for Gastroparesis Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Treatment for Gastroparesis Market Facts & Figures by Region
3.6.1 Asia Pacific Treatment for Gastroparesis Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Treatment for Gastroparesis Sales by Region (2021–2032)
3.6.3 Asia Pacific Treatment for Gastroparesis Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Treatment for Gastroparesis Market Facts & Figures by Country
3.7.1 Latin America Treatment for Gastroparesis Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Treatment for Gastroparesis Sales by Country (2021–2032)
3.7.3 Latin America Treatment for Gastroparesis Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Treatment for Gastroparesis Market Facts & Figures by Country
3.8.1 Middle East and Africa Treatment for Gastroparesis Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Treatment for Gastroparesis Sales by Country (2021–2032)
3.8.3 Middle East and Africa Treatment for Gastroparesis Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Treatment for Gastroparesis Sales by Type (2021–2032)
4.1.1 Global Treatment for Gastroparesis Sales by Type (2021–2026)
4.1.2 Global Treatment for Gastroparesis Sales by Type (2027–2032)
4.1.3 Global Treatment for Gastroparesis Sales Market Share by Type (2021–2032)
4.2 Global Treatment for Gastroparesis Revenue by Type (2021–2032)
4.2.1 Global Treatment for Gastroparesis Revenue by Type (2021–2026)
4.2.2 Global Treatment for Gastroparesis Revenue by Type (2027–2032)
4.2.3 Global Treatment for Gastroparesis Revenue Market Share by Type (2021–2032)
4.3 Global Treatment for Gastroparesis Price by Type (2021–2032)
5 Segment by Application
5.1 Global Treatment for Gastroparesis Sales by Application (2021–2032)
5.1.1 Global Treatment for Gastroparesis Sales by Application (2021–2026)
5.1.2 Global Treatment for Gastroparesis Sales by Application (2027–2032)
5.1.3 Global Treatment for Gastroparesis Sales Market Share by Application (2021–2032)
5.2 Global Treatment for Gastroparesis Revenue by Application (2021–2032)
5.2.1 Global Treatment for Gastroparesis Revenue by Application (2021–2026)
5.2.2 Global Treatment for Gastroparesis Revenue by Application (2027–2032)
5.2.3 Global Treatment for Gastroparesis Revenue Market Share by Application (2021–2032)
5.3 Global Treatment for Gastroparesis Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Janssen Global Services
6.1.1 Janssen Global Services Company Information
6.1.2 Janssen Global Services Description and Business Overview
6.1.3 Janssen Global Services Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Janssen Global Services Treatment for Gastroparesis Product Portfolio
6.1.5 Janssen Global Services Recent Developments/Updates
6.2 Evoke Pharma
6.2.1 Evoke Pharma Company Information
6.2.2 Evoke Pharma Description and Business Overview
6.2.3 Evoke Pharma Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Evoke Pharma Treatment for Gastroparesis Product Portfolio
6.2.5 Evoke Pharma Recent Developments/Updates
6.3 Cardinal Health
6.3.1 Cardinal Health Company Information
6.3.2 Cardinal Health Description and Business Overview
6.3.3 Cardinal Health Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Cardinal Health Treatment for Gastroparesis Product Portfolio
6.3.5 Cardinal Health Recent Developments/Updates
6.4 Salix Pharmaceuticals
6.4.1 Salix Pharmaceuticals Company Information
6.4.2 Salix Pharmaceuticals Description and Business Overview
6.4.3 Salix Pharmaceuticals Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Salix Pharmaceuticals Treatment for Gastroparesis Product Portfolio
6.4.5 Salix Pharmaceuticals Recent Developments/Updates
6.5 Alfa Wassermann
6.5.1 Alfa Wassermann Company Information
6.5.2 Alfa Wassermann Description and Business Overview
6.5.3 Alfa Wassermann Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Alfa Wassermann Treatment for Gastroparesis Product Portfolio
6.5.5 Alfa Wassermann Recent Developments/Updates
6.6 Abbott Laboratories
6.6.1 Abbott Laboratories Company Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Abbott Laboratories Treatment for Gastroparesis Product Portfolio
6.6.5 Abbott Laboratories Recent Developments/Updates
6.7 Medtronic
6.7.1 Medtronic Company Information
6.7.2 Medtronic Description and Business Overview
6.7.3 Medtronic Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Medtronic Treatment for Gastroparesis Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 C.R.Bard
6.8.1 C.R.Bard Company Information
6.8.2 C.R.Bard Description and Business Overview
6.8.3 C.R.Bard Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 C.R.Bard Treatment for Gastroparesis Product Portfolio
6.8.5 C.R.Bard Recent Developments/Updates
6.9 Rhythm Pharmaceuticals
6.9.1 Rhythm Pharmaceuticals Company Information
6.9.2 Rhythm Pharmaceuticals Description and Business Overview
6.9.3 Rhythm Pharmaceuticals Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Rhythm Pharmaceuticals Treatment for Gastroparesis Product Portfolio
6.9.5 Rhythm Pharmaceuticals Recent Developments/Updates
6.10 Boston Scientific
6.10.1 Boston Scientific Company Information
6.10.2 Boston Scientific Description and Business Overview
6.10.3 Boston Scientific Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Boston Scientific Treatment for Gastroparesis Product Portfolio
6.10.5 Boston Scientific Recent Developments/Updates
6.11 Kimberly-Clark
6.11.1 Kimberly-Clark Company Information
6.11.2 Kimberly-Clark Description and Business Overview
6.11.3 Kimberly-Clark Treatment for Gastroparesis Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Kimberly-Clark Treatment for Gastroparesis Product Portfolio
6.11.5 Kimberly-Clark Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Treatment for Gastroparesis Industry Chain Analysis
7.2 Treatment for Gastroparesis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Treatment for Gastroparesis Production Mode & Process Analysis
7.4 Treatment for Gastroparesis Sales and Marketing
7.4.1 Treatment for Gastroparesis Sales Channels
7.4.2 Treatment for Gastroparesis Distributors
7.5 Treatment for Gastroparesis Customer Analysis
8 Treatment for Gastroparesis Market Dynamics
8.1 Treatment for Gastroparesis Industry Trends
8.2 Treatment for Gastroparesis Market Drivers
8.3 Treatment for Gastroparesis Market Challenges
8.4 Treatment for Gastroparesis Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Treatment for Gastroparesis Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Treatment for Gastroparesis Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Treatment for Gastroparesis Market Competitive Situation by Manufacturers in 2025
Table 4. Global Treatment for Gastroparesis Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Treatment for Gastroparesis Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Treatment for Gastroparesis Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Treatment for Gastroparesis Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Treatment for Gastroparesis Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Treatment for Gastroparesis, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Treatment for Gastroparesis, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Treatment for Gastroparesis, Product Types and Applications
Table 12. Global Key Manufacturers of Treatment for Gastroparesis, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Treatment for Gastroparesis Companies by Tier (Tier 1, Tier 2, Tier 3), based on Treatment for Gastroparesis Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Treatment for Gastroparesis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Treatment for Gastroparesis Sales by Region (K Units), 2021–2026
Table 18. Global Treatment for Gastroparesis Sales Market Share by Region (2021–2026)
Table 19. Global Treatment for Gastroparesis Sales by Region (K Units), 2027–2032
Table 20. Global Treatment for Gastroparesis Sales Market Share by Region (2027–2032)
Table 21. Global Treatment for Gastroparesis Revenue by Region (US$ Million), 2021–2026
Table 22. Global Treatment for Gastroparesis Revenue Market Share by Region (2021–2026)
Table 23. Global Treatment for Gastroparesis Revenue by Region (US$ Million), 2027–2032
Table 24. Global Treatment for Gastroparesis Revenue Market Share by Region (2027–2032)
Table 25. North America Treatment for Gastroparesis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Treatment for Gastroparesis Sales by Country (K Units), 2021–2026
Table 27. North America Treatment for Gastroparesis Sales by Country (K Units), 2027–2032
Table 28. North America Treatment for Gastroparesis Revenue by Country (US$ Million), 2021–2026
Table 29. North America Treatment for Gastroparesis Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Treatment for Gastroparesis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Treatment for Gastroparesis Sales by Country (K Units), 2021–2026
Table 32. Europe Treatment for Gastroparesis Sales by Country (K Units), 2027–2032
Table 33. Europe Treatment for Gastroparesis Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Treatment for Gastroparesis Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Treatment for Gastroparesis Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Treatment for Gastroparesis Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Treatment for Gastroparesis Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Treatment for Gastroparesis Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Treatment for Gastroparesis Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Treatment for Gastroparesis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Treatment for Gastroparesis Sales by Country (K Units), 2021–2026
Table 42. Latin America Treatment for Gastroparesis Sales by Country (K Units), 2027–2032
Table 43. Latin America Treatment for Gastroparesis Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Treatment for Gastroparesis Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Treatment for Gastroparesis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Treatment for Gastroparesis Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Treatment for Gastroparesis Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Treatment for Gastroparesis Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Treatment for Gastroparesis Revenue by Country (US$ Million), 2027–2032
Table 50. Global Treatment for Gastroparesis Sales (K Units) by Type (2021–2026)
Table 51. Global Treatment for Gastroparesis Sales (K Units) by Type (2027–2032)
Table 52. Global Treatment for Gastroparesis Sales Market Share by Type (2021–2026)
Table 53. Global Treatment for Gastroparesis Sales Market Share by Type (2027–2032)
Table 54. Global Treatment for Gastroparesis Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Treatment for Gastroparesis Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Treatment for Gastroparesis Revenue Market Share by Type (2021–2026)
Table 57. Global Treatment for Gastroparesis Revenue Market Share by Type (2027–2032)
Table 58. Global Treatment for Gastroparesis Price (US$/Unit) by Type (2021–2026)
Table 59. Global Treatment for Gastroparesis Price (US$/Unit) by Type (2027–2032)
Table 60. Global Treatment for Gastroparesis Sales (K Units) by Application (2021–2026)
Table 61. Global Treatment for Gastroparesis Sales (K Units) by Application (2027–2032)
Table 62. Global Treatment for Gastroparesis Sales Market Share by Application (2021–2026)
Table 63. Global Treatment for Gastroparesis Sales Market Share by Application (2027–2032)
Table 64. Global Treatment for Gastroparesis Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Treatment for Gastroparesis Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Treatment for Gastroparesis Revenue Market Share by Application (2021–2026)
Table 67. Global Treatment for Gastroparesis Revenue Market Share by Application (2027–2032)
Table 68. Global Treatment for Gastroparesis Price (US$/Unit) by Application (2021–2026)
Table 69. Global Treatment for Gastroparesis Price (US$/Unit) by Application (2027–2032)
Table 70. Janssen Global Services Company Information
Table 71. Janssen Global Services Description and Business Overview
Table 72. Janssen Global Services Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Janssen Global Services Treatment for Gastroparesis Product
Table 74. Janssen Global Services Recent Developments/Updates
Table 75. Evoke Pharma Company Information
Table 76. Evoke Pharma Description and Business Overview
Table 77. Evoke Pharma Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Evoke Pharma Treatment for Gastroparesis Product
Table 79. Evoke Pharma Recent Developments/Updates
Table 80. Cardinal Health Company Information
Table 81. Cardinal Health Description and Business Overview
Table 82. Cardinal Health Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Cardinal Health Treatment for Gastroparesis Product
Table 84. Cardinal Health Recent Developments/Updates
Table 85. Salix Pharmaceuticals Company Information
Table 86. Salix Pharmaceuticals Description and Business Overview
Table 87. Salix Pharmaceuticals Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Salix Pharmaceuticals Treatment for Gastroparesis Product
Table 89. Salix Pharmaceuticals Recent Developments/Updates
Table 90. Alfa Wassermann Company Information
Table 91. Alfa Wassermann Description and Business Overview
Table 92. Alfa Wassermann Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Alfa Wassermann Treatment for Gastroparesis Product
Table 94. Alfa Wassermann Recent Developments/Updates
Table 95. Abbott Laboratories Company Information
Table 96. Abbott Laboratories Description and Business Overview
Table 97. Abbott Laboratories Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Abbott Laboratories Treatment for Gastroparesis Product
Table 99. Abbott Laboratories Recent Developments/Updates
Table 100. Medtronic Company Information
Table 101. Medtronic Description and Business Overview
Table 102. Medtronic Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Medtronic Treatment for Gastroparesis Product
Table 104. Medtronic Recent Developments/Updates
Table 105. C.R.Bard Company Information
Table 106. C.R.Bard Description and Business Overview
Table 107. C.R.Bard Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. C.R.Bard Treatment for Gastroparesis Product
Table 109. C.R.Bard Recent Developments/Updates
Table 110. Rhythm Pharmaceuticals Company Information
Table 111. Rhythm Pharmaceuticals Description and Business Overview
Table 112. Rhythm Pharmaceuticals Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Rhythm Pharmaceuticals Treatment for Gastroparesis Product
Table 114. Rhythm Pharmaceuticals Recent Developments/Updates
Table 115. Boston Scientific Company Information
Table 116. Boston Scientific Description and Business Overview
Table 117. Boston Scientific Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Boston Scientific Treatment for Gastroparesis Product
Table 119. Boston Scientific Recent Developments/Updates
Table 120. Kimberly-Clark Company Information
Table 121. Kimberly-Clark Description and Business Overview
Table 122. Kimberly-Clark Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Kimberly-Clark Treatment for Gastroparesis Product
Table 124. Kimberly-Clark Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Treatment for Gastroparesis Distributors List
Table 128. Treatment for Gastroparesis Customers List
Table 129. Treatment for Gastroparesis Market Trends
Table 130. Treatment for Gastroparesis Market Drivers
Table 131. Treatment for Gastroparesis Market Challenges
Table 132. Treatment for Gastroparesis Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Treatment for Gastroparesis
Figure 2. Global Treatment for Gastroparesis Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Treatment for Gastroparesis Market Share by Type: 2025 & 2032
Figure 4. Drugs Product Picture
Figure 5. Surgical Treatment Products Product Picture
Figure 6. Global Treatment for Gastroparesis Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Treatment for Gastroparesis Market Share by Application: 2025 & 2032
Figure 8. Hospital Pharmacies
Figure 9. Private Clinics
Figure 10. Drug Stores
Figure 11. Retail Pharmacies
Figure 12. E-Commerce
Figure 13. Global Treatment for Gastroparesis Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Treatment for Gastroparesis Market Size (US$ Million), 2021–2032
Figure 15. Global Treatment for Gastroparesis Sales (K Units), 2021–2032
Figure 16. Global Treatment for Gastroparesis Average Price (US$/Unit), 2021–2032
Figure 17. Treatment for Gastroparesis Report Years Considered
Figure 18. Treatment for Gastroparesis Sales Share by Manufacturers in 2025
Figure 19. Global Treatment for Gastroparesis Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Treatment for Gastroparesis Players: Market Share by Revenue in Treatment for Gastroparesis in 2025
Figure 21. Treatment for Gastroparesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Treatment for Gastroparesis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Treatment for Gastroparesis Sales Market Share by Country (2021–2032)
Figure 24. North America Treatment for Gastroparesis Revenue Market Share by Country (2021–2032)
Figure 25. United States Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Treatment for Gastroparesis Sales Market Share by Country (2021–2032)
Figure 28. Europe Treatment for Gastroparesis Revenue Market Share by Country (2021–2032)
Figure 29. Germany Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Treatment for Gastroparesis Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Treatment for Gastroparesis Revenue Market Share by Region (2021–2032)
Figure 36. China Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Indonesia Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Thailand Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Malaysia Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Treatment for Gastroparesis Sales Market Share by Country (2021–2032)
Figure 46. Latin America Treatment for Gastroparesis Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Treatment for Gastroparesis Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Treatment for Gastroparesis Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Treatment for Gastroparesis by Type (2021–2032)
Figure 56. Global Revenue Market Share of Treatment for Gastroparesis by Type (2021–2032)
Figure 57. Global Treatment for Gastroparesis Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Treatment for Gastroparesis by Application (2021–2032)
Figure 59. Global Revenue Market Share of Treatment for Gastroparesis by Application (2021–2032)
Figure 60. Global Treatment for Gastroparesis Price (US$/Unit) by Application (2021–2032)
Figure 61. Treatment for Gastroparesis Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Treatment for Gastroparesis Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Treatment for Gastroparesis Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Treatment for Gastroparesis Market Competitive Situation by Manufacturers in 2025
Table 4. Global Treatment for Gastroparesis Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Treatment for Gastroparesis Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Treatment for Gastroparesis Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Treatment for Gastroparesis Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Treatment for Gastroparesis Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Treatment for Gastroparesis, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Treatment for Gastroparesis, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Treatment for Gastroparesis, Product Types and Applications
Table 12. Global Key Manufacturers of Treatment for Gastroparesis, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Treatment for Gastroparesis Companies by Tier (Tier 1, Tier 2, Tier 3), based on Treatment for Gastroparesis Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Treatment for Gastroparesis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Treatment for Gastroparesis Sales by Region (K Units), 2021–2026
Table 18. Global Treatment for Gastroparesis Sales Market Share by Region (2021–2026)
Table 19. Global Treatment for Gastroparesis Sales by Region (K Units), 2027–2032
Table 20. Global Treatment for Gastroparesis Sales Market Share by Region (2027–2032)
Table 21. Global Treatment for Gastroparesis Revenue by Region (US$ Million), 2021–2026
Table 22. Global Treatment for Gastroparesis Revenue Market Share by Region (2021–2026)
Table 23. Global Treatment for Gastroparesis Revenue by Region (US$ Million), 2027–2032
Table 24. Global Treatment for Gastroparesis Revenue Market Share by Region (2027–2032)
Table 25. North America Treatment for Gastroparesis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Treatment for Gastroparesis Sales by Country (K Units), 2021–2026
Table 27. North America Treatment for Gastroparesis Sales by Country (K Units), 2027–2032
Table 28. North America Treatment for Gastroparesis Revenue by Country (US$ Million), 2021–2026
Table 29. North America Treatment for Gastroparesis Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Treatment for Gastroparesis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Treatment for Gastroparesis Sales by Country (K Units), 2021–2026
Table 32. Europe Treatment for Gastroparesis Sales by Country (K Units), 2027–2032
Table 33. Europe Treatment for Gastroparesis Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Treatment for Gastroparesis Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Treatment for Gastroparesis Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Treatment for Gastroparesis Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Treatment for Gastroparesis Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Treatment for Gastroparesis Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Treatment for Gastroparesis Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Treatment for Gastroparesis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Treatment for Gastroparesis Sales by Country (K Units), 2021–2026
Table 42. Latin America Treatment for Gastroparesis Sales by Country (K Units), 2027–2032
Table 43. Latin America Treatment for Gastroparesis Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Treatment for Gastroparesis Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Treatment for Gastroparesis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Treatment for Gastroparesis Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Treatment for Gastroparesis Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Treatment for Gastroparesis Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Treatment for Gastroparesis Revenue by Country (US$ Million), 2027–2032
Table 50. Global Treatment for Gastroparesis Sales (K Units) by Type (2021–2026)
Table 51. Global Treatment for Gastroparesis Sales (K Units) by Type (2027–2032)
Table 52. Global Treatment for Gastroparesis Sales Market Share by Type (2021–2026)
Table 53. Global Treatment for Gastroparesis Sales Market Share by Type (2027–2032)
Table 54. Global Treatment for Gastroparesis Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Treatment for Gastroparesis Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Treatment for Gastroparesis Revenue Market Share by Type (2021–2026)
Table 57. Global Treatment for Gastroparesis Revenue Market Share by Type (2027–2032)
Table 58. Global Treatment for Gastroparesis Price (US$/Unit) by Type (2021–2026)
Table 59. Global Treatment for Gastroparesis Price (US$/Unit) by Type (2027–2032)
Table 60. Global Treatment for Gastroparesis Sales (K Units) by Application (2021–2026)
Table 61. Global Treatment for Gastroparesis Sales (K Units) by Application (2027–2032)
Table 62. Global Treatment for Gastroparesis Sales Market Share by Application (2021–2026)
Table 63. Global Treatment for Gastroparesis Sales Market Share by Application (2027–2032)
Table 64. Global Treatment for Gastroparesis Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Treatment for Gastroparesis Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Treatment for Gastroparesis Revenue Market Share by Application (2021–2026)
Table 67. Global Treatment for Gastroparesis Revenue Market Share by Application (2027–2032)
Table 68. Global Treatment for Gastroparesis Price (US$/Unit) by Application (2021–2026)
Table 69. Global Treatment for Gastroparesis Price (US$/Unit) by Application (2027–2032)
Table 70. Janssen Global Services Company Information
Table 71. Janssen Global Services Description and Business Overview
Table 72. Janssen Global Services Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Janssen Global Services Treatment for Gastroparesis Product
Table 74. Janssen Global Services Recent Developments/Updates
Table 75. Evoke Pharma Company Information
Table 76. Evoke Pharma Description and Business Overview
Table 77. Evoke Pharma Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Evoke Pharma Treatment for Gastroparesis Product
Table 79. Evoke Pharma Recent Developments/Updates
Table 80. Cardinal Health Company Information
Table 81. Cardinal Health Description and Business Overview
Table 82. Cardinal Health Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Cardinal Health Treatment for Gastroparesis Product
Table 84. Cardinal Health Recent Developments/Updates
Table 85. Salix Pharmaceuticals Company Information
Table 86. Salix Pharmaceuticals Description and Business Overview
Table 87. Salix Pharmaceuticals Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Salix Pharmaceuticals Treatment for Gastroparesis Product
Table 89. Salix Pharmaceuticals Recent Developments/Updates
Table 90. Alfa Wassermann Company Information
Table 91. Alfa Wassermann Description and Business Overview
Table 92. Alfa Wassermann Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Alfa Wassermann Treatment for Gastroparesis Product
Table 94. Alfa Wassermann Recent Developments/Updates
Table 95. Abbott Laboratories Company Information
Table 96. Abbott Laboratories Description and Business Overview
Table 97. Abbott Laboratories Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Abbott Laboratories Treatment for Gastroparesis Product
Table 99. Abbott Laboratories Recent Developments/Updates
Table 100. Medtronic Company Information
Table 101. Medtronic Description and Business Overview
Table 102. Medtronic Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Medtronic Treatment for Gastroparesis Product
Table 104. Medtronic Recent Developments/Updates
Table 105. C.R.Bard Company Information
Table 106. C.R.Bard Description and Business Overview
Table 107. C.R.Bard Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. C.R.Bard Treatment for Gastroparesis Product
Table 109. C.R.Bard Recent Developments/Updates
Table 110. Rhythm Pharmaceuticals Company Information
Table 111. Rhythm Pharmaceuticals Description and Business Overview
Table 112. Rhythm Pharmaceuticals Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Rhythm Pharmaceuticals Treatment for Gastroparesis Product
Table 114. Rhythm Pharmaceuticals Recent Developments/Updates
Table 115. Boston Scientific Company Information
Table 116. Boston Scientific Description and Business Overview
Table 117. Boston Scientific Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Boston Scientific Treatment for Gastroparesis Product
Table 119. Boston Scientific Recent Developments/Updates
Table 120. Kimberly-Clark Company Information
Table 121. Kimberly-Clark Description and Business Overview
Table 122. Kimberly-Clark Treatment for Gastroparesis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Kimberly-Clark Treatment for Gastroparesis Product
Table 124. Kimberly-Clark Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Treatment for Gastroparesis Distributors List
Table 128. Treatment for Gastroparesis Customers List
Table 129. Treatment for Gastroparesis Market Trends
Table 130. Treatment for Gastroparesis Market Drivers
Table 131. Treatment for Gastroparesis Market Challenges
Table 132. Treatment for Gastroparesis Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Treatment for Gastroparesis
Figure 2. Global Treatment for Gastroparesis Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Treatment for Gastroparesis Market Share by Type: 2025 & 2032
Figure 4. Drugs Product Picture
Figure 5. Surgical Treatment Products Product Picture
Figure 6. Global Treatment for Gastroparesis Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Treatment for Gastroparesis Market Share by Application: 2025 & 2032
Figure 8. Hospital Pharmacies
Figure 9. Private Clinics
Figure 10. Drug Stores
Figure 11. Retail Pharmacies
Figure 12. E-Commerce
Figure 13. Global Treatment for Gastroparesis Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Treatment for Gastroparesis Market Size (US$ Million), 2021–2032
Figure 15. Global Treatment for Gastroparesis Sales (K Units), 2021–2032
Figure 16. Global Treatment for Gastroparesis Average Price (US$/Unit), 2021–2032
Figure 17. Treatment for Gastroparesis Report Years Considered
Figure 18. Treatment for Gastroparesis Sales Share by Manufacturers in 2025
Figure 19. Global Treatment for Gastroparesis Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Treatment for Gastroparesis Players: Market Share by Revenue in Treatment for Gastroparesis in 2025
Figure 21. Treatment for Gastroparesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Treatment for Gastroparesis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Treatment for Gastroparesis Sales Market Share by Country (2021–2032)
Figure 24. North America Treatment for Gastroparesis Revenue Market Share by Country (2021–2032)
Figure 25. United States Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Treatment for Gastroparesis Sales Market Share by Country (2021–2032)
Figure 28. Europe Treatment for Gastroparesis Revenue Market Share by Country (2021–2032)
Figure 29. Germany Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Treatment for Gastroparesis Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Treatment for Gastroparesis Revenue Market Share by Region (2021–2032)
Figure 36. China Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Indonesia Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Thailand Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Malaysia Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Treatment for Gastroparesis Sales Market Share by Country (2021–2032)
Figure 46. Latin America Treatment for Gastroparesis Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Treatment for Gastroparesis Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Treatment for Gastroparesis Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Treatment for Gastroparesis Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Treatment for Gastroparesis by Type (2021–2032)
Figure 56. Global Revenue Market Share of Treatment for Gastroparesis by Type (2021–2032)
Figure 57. Global Treatment for Gastroparesis Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Treatment for Gastroparesis by Application (2021–2032)
Figure 59. Global Revenue Market Share of Treatment for Gastroparesis by Application (2021–2032)
Figure 60. Global Treatment for Gastroparesis Price (US$/Unit) by Application (2021–2032)
Figure 61. Treatment for Gastroparesis Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Physical Graphing Calculators Market Research Report 2026
Nov 14, 26
Global Graphics Calculators Market Research Report 2026
Nov 14, 26
Global Internet and Wi-fi Connected Smart Dishwashers Market Research Report 2026
Nov 14, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232